Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin Supplements and Eye Disease in Women
NCT00000161Phase 3Unknown
- Sponsor
- National Eye Institute
- Start
- Aug 1993
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, double-blind trial of aspirin, vitamin e, ascorbic acid and beta-carotene in cataract and age-related macular degeneration (AMD) (4 arms), sponsored by National Eye Institute. Primary endpoints: Incidence of Cataract at 12 months and Incidence of Age-Related Macular Degeneration at 12 months. Status: unknown.
02
Drugs
aspirinvitamin eascorbic acidbeta-carotene
03
Conditions
cataractage-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00000161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000161.